NAT-ALPRAZOLAM

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: 9acaa2fdcd43030c
Drug Approval Canada Name: NAT-ALPRAZOLAM
Product Name: NAT-ALPRAZOLAM
Status: Cancelled Post Market
Status Date: 2018-06-30
Original Market Date: 2016-05-05
Din: 02417669
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Targeted (CDSA IV)
Ahfs: 28:24.08
Atc Original: N05BA12 ALPRAZOLAM
Atc Name: n 05 ba 12
Aig Number: 0115008004
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

ALPRAZOLAM

2 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

9acaa2fdcd43030c

Type

Standard